Geoffrey Candy to Cardiomyopathy, Dilated
This is a "connection" page, showing publications Geoffrey Candy has written about Cardiomyopathy, Dilated.
Connection Strength
0,380
-
Association of left ventricular systolic performance and cavity size with angiotensin-converting enzyme genotype in idiopathic dilated cardiomyopathy. Am J Cardiol. 1999 Mar 01; 83(5):740-4.
Score: 0,156
-
Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol. 2002 Nov 15; 90(10):1118-22.
Score: 0,050
-
An aldosterone synthase gene variant is associated with improvement in left ventricular ejection fraction in dilated cardiomyopathy. Cardiovasc Res. 2002 Jun; 54(3):584-9.
Score: 0,049
-
Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study. Circulation. 2001 Feb 27; 103(8):1083-8.
Score: 0,045
-
Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline. Heart. 2000 Oct; 84(4):438-9.
Score: 0,044
-
Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy. Lancet. 1998 Apr 11; 351(9109):1091-3.
Score: 0,037